Phase 3CompletedAge-related condition
Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia
A Randomized, Double Blind, Placebo Controlled, Parallel Group, Multi-Center Study With a Double Blind Extension Investigating the Efficacy and Safety of a Fast- Dissolving ("Melt") Formulation of Desmopressin for the Treatment of Nocturia in Adults
- Sponsor
- Ferring Pharmaceuticals (Industry)
- Enrollment
- 799 enrolled
- Conditions
- Nocturia
- Interventions
- desmopressin acetate; Placebo
- Ages
- adults, older adults
- Registry
- NCT00477490
Full record on ClinicalTrials.gov
From the registry
The purpose of this study is to investigate the efficacy and safety of several doses of the melt formulation of desmopressin in a broad population of adult patients with nocturia.
Primary outcomes
- Part I: Change From Baseline in Mean Number of Nocturnal Voids at Week 4
- Part I: Percentage of Participants With Greater Than 33 Percent Reduction From Baseline in Mean Number of Nocturnal Voids at Week 4
History
Results first posted
Last registry update
Primary completion
Registered
Started